[1]王雄文,乔翠霞,张俊萍,邓运宗,王红玲,熊绍权,罗秋月,方灿途,李陆振,王斌,田华琴,梁燕玲,周岱翰,成金乐.参芪固本方破壁饮片与传统汤剂联合鹤蟾片治疗ⅢB、Ⅳ期非小细胞肺癌的疗效及安全性研究[J].中医肿瘤学杂志,2021,3(03):18-23+35.

[2]李修身,周岱翰.清金得生片联合化疗治疗中晚期非小细胞肺癌回顾性临床研究[J].中医肿瘤学杂志,2020,2(05):24-28.

[3]廖彩捷,周岱翰.《临证指南医案》治疗噎膈反胃的用药规律及辨治特色[J].中医肿瘤学杂志,2020,2(04):7-10.

[4]江海媚,唐莹,张恩欣,黄海福,周瑞生,周岱翰.参桃软肝方对肝细胞癌HepG2细胞作用机制的研究[J].中医肿瘤学杂志,2020,2(04):54-60.

[5]蒋梅,张恩欣,杨丽廷,成东茹,贺凡,谭定英,周岱翰.周岱翰治疗脾虚痰湿型非小细胞肺癌的用药组方规律探讨[J].广州中医药大学学报,2020,37(02):348-353.

[6]周岱翰.《伤寒杂病论》治癌优势原理与经方辨治肝癌临床运用[J].中医肿瘤学杂志,2019,1(04):1-6.

[7]周岱翰.中医肿瘤学发展历程的反思与展望[J].中医肿瘤学杂志,2019,1(02):1-5+9.

[8] Zhou, Rui-sheng; Wang, Xiong-Wen; Sun, Qin-feng; Ye, Zeng Jie; Liu, Jian-wei; Zhou, Dai-Han; Tang, Ying*; Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis, Biomed Research International, 2019, 2019: 3065818.

[9] Tang, Ying#; Jiang, Mei#; Jiang, Hai-Mei#; Ye, Zeng Jie; Huang, Yu-Sheng; Li, Xiu-Shen; Qin, Bin-Yu; Zhou, Rui-Sheng; Pan, Hua-Feng*; Zheng, Da-Yong*; The Roles of circRNAs in Liver Cancer Immunity, Front Oncol, 2020,10: 0-598464

[10] Zeng, Zhili#; Cao, Zebiao#; Tang, Ying*; Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data , BMC Cancer, 2020, 20(1): 1037.

[11] Zeng, Zhili#; Cao, Zebiao#; Zhang, Enxin*; Huang, Haifu*; Tang, Ying*; Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data, Bioscience Reports, 2021, 41(1).

[12] Zeng, Zhili#; Cao, Zebiao#; Tang, Ying*; Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data, Oncology Letters, 2020, 20(5): 231.

[13] Li, Xiu-Shen#; Nie, Ke-Chao#; Zheng, Zhi-Hua#; Zhou, Rui-Sheng; Huang, Yu-Sheng; Ye, Zeng-Jie; He, Fan; Tang, Ying*; Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma, BMC Cancer, 2021, 21(1): 0-96.

[14] Zhou, Rui-Sheng#; Zhang, En-Xin#; Sun, Qin-Feng; Ye, Zeng-Jie; Liu, Jian-Wei; Zhou, Dai-Han; Tang, Ying*; Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue, BMC Cancer, 2019, 19(1): 0-779.